Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovis (ENOV) Liabilities and Shareholders Equity (2016 - 2025)

Enovis (ENOV) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $3.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 18.73% to $3.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $18.2 billion, a 14.28% decrease, with the full-year FY2025 number at $3.8 billion, down 18.73% from a year prior.
  • Liabilities and Shareholders Equity was $3.8 billion for Q4 2025 at Enovis, down from $4.4 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $8.5 billion in Q4 2021 to a low of $1.8 billion in Q2 2022.
  • A 5-year average of $5.2 billion and a median of $4.6 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: crashed 77.69% in 2022, then surged 138.87% in 2023.
  • Enovis' Liabilities and Shareholders Equity stood at $8.5 billion in 2021, then plummeted by 49.82% to $4.3 billion in 2022, then grew by 5.52% to $4.5 billion in 2023, then increased by 4.64% to $4.7 billion in 2024, then decreased by 18.73% to $3.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ENOV's Liabilities and Shareholders Equity are $3.8 billion (Q4 2025), $4.4 billion (Q4 2025), and $5.0 billion (Q3 2025).